Development of BN Heterocycles for Biomedical Research

用于生物医学研究的氮化硼杂环化合物的开发

基本信息

  • 批准号:
    8518381
  • 负责人:
  • 金额:
    $ 28.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2015-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Boron-containing compounds have recently emerged as useful biologically active substances with unique mechanisms of action. This proposal describes a program in synthetic chemistry geared toward developing boron-nitrogen-containing heterocycles (BN heterocycles) for use in biomedical research. Specifically, we are interested in 1,2-azaborine heterocycles, which are aromatic compounds isosteric with arenes. The broad utility and fundamental importance of arenes combined with the unique elemental and chemical features of boron make 1,2-azaborines attractive targets for biomedical investigations. Potential benefits of research into boron-based drugs include discovery of novel boron-specific mechanisms of biological activity that are unattainable by conventional organic molecules and attenuated development of drug resistance by targeted pathogens. We outline a synthetic program for the preparation of 1,2-azaborine derivatives, a physical organic program that uses a combined synthetic, structural, spectroscopic, and computational approach to address the aromaticity and reactivity of 1,2-azaborines, and a chemical biology program to establish the reactivity and interactions of BN heterocycles in a biological environment. Our proposed studies will enhance the fundamental understanding of the structure, bonding, and aromaticity the 1,2-azaborine heterocycle and illuminate the changes in the properties of classic aromatic organic molecules (e.g., benzene and indole) upon the replacement of a C=C bond with the isostructural inorganic B-N unit. The basic science resulting from the proposed work will bring new impetus to the chemistry of novel aromatics while at the same time promote the design and development of new boron-derived biologically active compounds with improved pharmacological profiles and new mechanistic tools for chemical biology. PUBLIC HEALTH RELEVANCE: This proposal describes a program in synthetic chemistry geared toward developing boron-nitrogen-containing heterocycles (BN heterocycles) for use in biomedical research. Potential benefits of research into boron-based drugs include discovery of novel boron-specific mechanisms of biological activity that are unattainable by conventional organic molecules and attenuated development of drug resistance by targeted pathogens. The proposed basic research will yield new fundamental knowledge and promote the design and development of new boron-derived biologically active compounds with improved pharmacological profiles.
描述(由申请人提供):含硼化合物是最近出现的有用的生物活性物质,具有独特的作用机制。本提案描述了一个合成化学项目,旨在开发用于生物医学研究的含硼氮杂环(BN杂环)。具体来说,我们对1,2-氮杂环很感兴趣,这是一种与芳烃等构的芳香化合物。芳烃的广泛用途和基本重要性,结合硼独特的元素和化学特性,使1,2-氮杂核糖成为生物医学研究的有吸引力的目标。硼基药物研究的潜在好处包括发现新的硼特异性生物活性机制,这是传统有机分子无法实现的,并减轻了目标病原体的耐药性。我们概述了一个制备1,2-氮杂环衍生物的合成程序,一个物理有机程序,使用合成,结构,光谱和计算相结合的方法来解决1,2-氮杂环的芳香性和反应性,以及一个化学生物学程序来建立BN杂环在生物环境中的反应性和相互作用。我们提出的研究将增强对1,2-氮杂环的结构、成键和芳香性的基本理解,并阐明经典芳香有机分子(如苯和吲哚)在用同构无机B-N单元取代C=C键后性质的变化。所提出的工作所产生的基础科学将为新型芳香化合物的化学研究带来新的动力,同时促进新的硼源生物活性化合物的设计和开发,这些化合物具有改进的药理特征和化学生物学的新机制工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Shih-Yuan Liu其他文献

Shih-Yuan Liu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Shih-Yuan Liu', 18)}}的其他基金

Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
  • 批准号:
    10387406
  • 财政年份:
    2020
  • 资助金额:
    $ 28.41万
  • 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
  • 批准号:
    10121469
  • 财政年份:
    2020
  • 资助金额:
    $ 28.41万
  • 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
  • 批准号:
    10455044
  • 财政年份:
    2020
  • 资助金额:
    $ 28.41万
  • 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
  • 批准号:
    10663272
  • 财政年份:
    2020
  • 资助金额:
    $ 28.41万
  • 项目类别:
Novel Reagents and Catalysts for Organic Synthesis
用于有机合成的新型试剂和催化剂
  • 批准号:
    10263287
  • 财政年份:
    2020
  • 资助金额:
    $ 28.41万
  • 项目类别:
Novel Azaborine Derivatives Predicted to Eliminate Acetaminophen Hepatotoxicity
新型氮杂硼啉衍生物有望消除对乙酰氨基酚的肝毒性
  • 批准号:
    8195745
  • 财政年份:
    2011
  • 资助金额:
    $ 28.41万
  • 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
  • 批准号:
    7949958
  • 财政年份:
    2010
  • 资助金额:
    $ 28.41万
  • 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
  • 批准号:
    9173274
  • 财政年份:
    2010
  • 资助金额:
    $ 28.41万
  • 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
  • 批准号:
    8733176
  • 财政年份:
    2010
  • 资助金额:
    $ 28.41万
  • 项目类别:
Development of BN Heterocycles for Biomedical Research
用于生物医学研究的氮化硼杂环化合物的开发
  • 批准号:
    8306276
  • 财政年份:
    2010
  • 资助金额:
    $ 28.41万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Studentship
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
    Continuing Grant
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 28.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了